E‐cadherin low levels were observed in HCC (C1, C2) (Fig. 6B), indicating that EMT remained enhanced in UBE2T‐driven HCC after MK‐2206 treatment. This evidence concerns the gene CDH1 and hepatocellular carcinoma.